Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

Also called NCT03150667

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03150667
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03150667. Randomized; no masking; primary purpose prevention. Start 2017-04-10 (actual); primary completion 2019-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
Acronym
CPRS-CKD
Condition
Chronic Kidney Diseases
Condition
Acute Coronary Syndrome
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Lead sponsor
North Texas Veterans Healthcare System (class: US federal agency)

Record details

Record id
cardio:ct-nct03150667
Content hash
82fd6aedf45eef0a79f0f77dcfd90cf21c062ca5d254a6fff4bb083cfbf3048e